玫瑰痤疮发病机制的研究进展

doi:10.35541/cjd.20230536

Abstract

Liu Tingwei, Meng Xiaoqi, Gu Duoduo, Pan Ruoxin, Zhang Yue, Xu Yang. Advances in the pathogenesis of rosacea[J]. Chinese Journal of Dermatology, 2024, 57(2): 186-190.doi:10.35541/cjd.20230536

References ［48］

［1］	van Zuuren EJ, Arents B, van der Linden M, et al. Rosacea: new concepts in classification and treatment［J］. Am J Clin Dermatol, 2021,22（4）:457⁃465. doi: 10.1007/s40257⁃021⁃00595⁃7.
［2］	Chang HC, Huang YC, Lien YJ, et al. Association of rosacea with depression and anxiety: a systematic review and meta⁃analysis［J］. J Affect Disord, 2022,299:239⁃245. doi: 10.1016/j.jad.2021. 12.008.
［3］	Gether L, Overgaard LK, Egeberg A, et al. Incidence and prevalence of rosacea: a systematic review and meta⁃analysis［J］. Br J Dermatol, 2018,179（2）:282⁃289. doi: 10.1111/bjd.16481.
［4］	Thiboutot D, Anderson R, Cook⁃Bolden F, et al. Standard management options for rosacea: the 2019 update by the National Rosacea Society Expert Committee［J］. J Am Acad Dermatol, 2020,82（6）:1501⁃1510. doi: 10.1016/j.jaad.2020.01. 077.
［5］	Xiao W, Li J, Huang X, et al. Mediation roles of neutrophils and high⁃density lipoprotein （HDL） on the relationship between HLA⁃DQB1 and rosacea［J］. Ann Med, 2022,54（1）:1530⁃1537. doi: 10.1080/07853890.2022.2077427.
［6］	Deng Z, Chen M, Zhao Z, et al. Whole genome sequencing identifies genetic variants associated with neurogenic inflammation in rosacea［J］. Nat Commun, 2023,14（1）:3958. doi: 10.1038/s41467⁃023⁃39761⁃2.
［7］	中华医学会皮肤性病学分会玫瑰痤疮研究中心, 中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南（2021版）［J］. 中华皮肤科杂志, 2021,54（4）:279⁃288. doi: 10.35541/cjd.20201078.
［8］	Zhang C, Kang Y, Zhang Z, et al. Long⁃term administration of LL⁃37 can induce irreversible rosacea⁃like lesion［J］. Curr Issues Mol Biol, 2023,45（4）:2703⁃2716. doi: 10.3390/cimb45040177.
［9］	Yoon SH, Hwang I, Lee E, et al. Antimicrobial peptide LL⁃37 drives rosacea⁃like skin inflammation in an NLRP3⁃dependent manner［J］. J Invest Dermatol, 2021,141（12）:2885⁃2894.e5. doi: 10.1016/j.jid.2021.02.745.
［10］	Deng Z, Chen M, Liu Y, et al. A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea［J］. EMBO Mol Med, 2021,13（5）:e13560. doi: 10.15252/emmm. 202013560.
［11］	Shih YH, Xu J, Kumar A, et al. Alterations of immune and keratinization gene expression in papulopustular rosacea by whole transcriptome analysis［J］. J Invest Dermatol, 2020,140（5）:1100⁃1103.e4. doi: 10.1016/j.jid.2019.09.021.
［12］	Sun YH, Man XY, Xuan XY, et al. Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: a retrospective case series［J］. Dermatol Ther, 2022,35（11）:e15848. doi: 10.1111/dth.15848.
［13］	Wang L, Wang YJ, Hao D, et al. The theranostics role of mast cells in the pathophysiology of rosacea［J］. Front Med （Lausanne）, 2019,6:324. doi: 10.3389/fmed.2019.00324.
［14］	Muto Y, Wang Z, Vanderberghe M, et al. Mast cells are key mediators of cathelicidin⁃initiated skin inflammation in rosacea［J］. J Invest Dermatol, 2014,134（11）:2728⁃2736. doi: 10.1038/jid.2014.222.
［15］	Mascarenhas NL, Wang Z, Chang YL, et al. TRPV4 mediates mast cell activation in cathelicidin⁃induced rosacea inflammation［J］. J Invest Dermatol, 2017,137（4）:972⁃975. doi: 10.1016/j.jid.2016.10.046.
［16］	Al Hamwi G, Riedel YK, Clemens S, et al. MAS⁃related G protein⁃coupled receptors X （MRGPRX）: Orphan GPCRs with potential as targets for future drugs［J］. Pharmacol Ther, 2022,238:108259. doi: 10.1016/j.pharmthera.2022.108259.
［17］	Cao C, Kang HJ, Singh I, et al. Structure, function and pharmacology of human itch GPCRs［J］. Nature, 2021,600（7887）:170⁃175. doi: 10.1038/s41586⁃021⁃04126⁃6.
［18］	Zhou L, Zhao H, Zhao H, et al. GBP5 exacerbates rosacea⁃like skin inflammation by skewing macrophage polarization towards M1 phenotype through the NF⁃κB signalling pathway［J］. J Eur Acad Dermatol Venereol, 2023,37（4）:796⁃809. doi: 10.1111/jdv.18725.
［19］	Liu Z, Zhang J, Jiang P, et al. Paeoniflorin inhibits the macrophage⁃related rosacea⁃like inflammatory reaction through the suppressor of cytokine signaling 3⁃apoptosis signal⁃regulating kinase 1⁃p38 pathway［J］. Medicine （Baltimore）, 2021,100（3）:e23986. doi: 10.1097/MD.0000000000023986.
［20］	Zhao Z, Liu T, Liang Y, et al. N2⁃polarized neutrophils reduce inflammation in rosacea by regulating vascular factors and proliferation of CD4+ T cells［J］. J Invest Dermatol, 2022,142（7）:1835⁃1844.e2. doi: 10.1016/j.jid.2021.12.009.
［21］	Buhl T, Sulk M, Nowak P, et al. Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1/Th17 pathways［J］. J Invest Dermatol, 2015,135（9）:2198⁃2208. doi: 10.1038/jid.2015.141.
［22］	Holmes AD, Steinhoff M. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics［J］. Exp Dermatol, 2017,26（8）:659⁃667. doi: 10.1111/exd.13143.
［23］	Sinikumpu SP, Vähänikkilä H, Jokelainen J, et al. Male patients with rosacea have increased risk for migraine: a population⁃based study［J］. Br J Dermatol, 2021,185（5）:1058⁃1061. doi: 10.1111/bjd.20578.
［24］	Liu Y, Xu Y, Guo Z, et al. Identifying the neural basis for rosacea using positron emission tomography⁃computed tomography cerebral functional imaging analysis: a cross⁃sectional study［J］. Skin Res Technol, 2022,28（5）:708⁃713. doi: 10.1111/srt.13171.
［25］	刘乙萱, 姜沛彧,刘韵祎, 等. 玫瑰痤疮神经源性炎症及肉毒毒素治疗相关机制的研究进展［J］. 中华皮肤科杂志, 2022,55（6）:552⁃554. doi:10.35541/cjd.20200266.
［26］	Li M, Tao M, Zhang Y, et al. Neurogenic rosacea could be a small fiber neuropathy［J］. Front Pain Res （Lausanne）, 2023,4:1122134. doi: 10.3389/fpain.2023.1122134.
［27］	Choi JE, Di Nardo A. Skin neurogenic inflammation［J］. Semin Immunopathol, 2018,40（3）:249⁃259. doi: 10.1007/s00281⁃018⁃0675⁃z.
［28］	Kim HB, Na EY, Yun SJ, et al. The effect of capsaicin on neuroinflammatory mediators of rosacea［J］. Ann Dermatol, 2022,34（4）:261⁃269. doi: 10.5021/ad.21.223.
［29］	Marek⁃Jozefowicz L, Nedoszytko B, Grochocka M, et al. Molecular mechanisms of neurogenic inflammation of the skin［J］. Int J Mol Sci, 2023,24（5）:5001. doi: 10.3390/ijms2405 5001.
［30］	Jovanovic Z, Angabini N, Ehlen S, et al. Efficacy and tolerability of a cosmetic skin care product with trans⁃4⁃t⁃butylcyclohexanol and licochalcone A in subjects with sensitive skin prone to redness and rosacea［J］. J Drugs Dermatol, 2017,16（6）:605⁃610.
［31］	Kim HO, Kang SY, Kim KE, et al. Neurogenic rosacea in Korea［J］. J Dermatol, 2021,48（1）:49⁃55. doi: 10.1111/1346⁃8138. 15629.
［32］	Zhou X, Su Y, Wu S, et al. The temperature⁃sensitive receptors TRPV4 and TRPM8 have important roles in the pruritus of rosacea［J］. J Dermatol Sci, 2022,108（2）:68⁃76. doi: 10.1016/j.jdermsci.2022.11.004.
［33］	Liu T, Xiao W, Chen M, et al. Aberrant amino acid metabolism promotes neurovascular reactivity in rosacea［J］. JCI Insight, 2022,7（22）:e161870. doi: 10.1172/jci.insight.161870.
［34］	Kim J, Choi S, Choi S, et al. Contact hypersensitivity and Demodex mite infestation in patients with rosacea: a retro⁃spective cohort analysis［J］. Eur J Dermatol, 2022,32（6）:716⁃723. doi: 10.1684/ejd.2022.4358.
［35］	Lee SG, Kim J, Lee YI, et al. Cutaneous neurogenic inflammation mediated by TRPV1⁃NGF⁃TRKA pathway activation in rosacea is exacerbated by the presence of Demodex mites［J］. J Eur Acad Dermatol Venereol, 2023,37（12）:2589⁃2600. doi: 10.1111/jdv. 19449.
［36］	Zaidi AK, Spaunhurst K, Sprockett D, et al. Characterization of the facial microbiome in twins discordant for rosacea［J］. Exp Dermatol, 2018,27（3）:295⁃298. doi: 10.1111/exd.13491.
［37］	Rainer BM, Thompson KG, Antonescu C, et al. Characterization and analysis of the skin microbiota in rosacea: a case⁃control study［J］. Am J Clin Dermatol, 2020,21（1）:139⁃147. doi: 10. 1007/s40257⁃019⁃00471⁃5.
［38］	Zhang Y, Zhou Y, Humbert P, et al. Effect on the skin microbiota of oral minocycline for rosacea［J］. Acta Derm Venereol, 2023,103:adv10331. doi: 10.2340/actadv.v103.10331.
［39］	Mahmud MR, Akter S, Tamanna SK, et al. Impact of gut microbiome on skin health: gut⁃skin axis observed through the lenses of therapeutics and skin diseases［J］. Gut Microbes, 2022,14（1）:2096995. doi: 10.1080/19490976.2022.2096995.
［40］	Sinha S, Lin G, Ferenczi K. The skin microbiome and the gut⁃skin axis［J］. Clin Dermatol, 2021,39（5）:829⁃839. doi: 10.1016/j.clindermatol.2021.08.021.
［41］	Baldwin H, Alexis AF, Andriessen A, et al. Evidence of barrier deficiency in rosacea and the importance of integrating OTC skincare products into treatment regimens［J］. J Drugs Dermatol, 2021,20（4）:384⁃392. doi: 10.36849/JDD.2021.5861.
［42］	Medgyesi B, Dajnoki Z, Béke G, et al. Rosacea is characterized by a profoundly diminished skin barrier［J］. J Invest Dermatol, 2020,140（10）:1938⁃1950.e5. doi: 10.1016/j.jid.2020.02.025.
［43］	Passeron T, Zouboulis CC, Tan J, et al. Adult skin acute stress responses to short⁃term environmental and internal aggression from exposome factors［J］. J Eur Acad Dermatol Venereol, 2021,35（10）:1963⁃1975. doi: 10.1111/jdv.17432.
［44］	Deng Z, Chen M, Xie H, et al. Claudin reduction may relate to an impaired skin barrier in rosacea［J］. J Dermatol, 2019,46（4）:314⁃321. doi: 10.1111/1346⁃8138.14792.
［45］	Wang Y, Wang B, Huang Y, et al. Multi⁃transcriptomic analysis and experimental validation implicate a central role of STAT3 in skin barrier dysfunction induced aggravation of rosacea［J］. J Inflamm Res, 2022,15:2141⁃2156. doi: 10.2147/JIR.S356551.
［46］	Suhng E, Kim BH, Choi YW, et al. Increased expression of IL⁃33 in rosacea skin and UVB⁃irradiated and LL⁃37⁃treated HaCaT cells［J］. Exp Dermatol, 2018,27（9）:1023⁃1029. doi: 10.1111/exd.13702.
［47］	Kulkarni NN, Takahashi T, Sanford JA, et al. Innate immune dysfunction in rosacea promotes photosensitivity and vascular adhesion molecule expression［J］. J Invest Dermatol, 2020,140（3）:645⁃655.e6. doi: 10.1016/j.jid.2019.08.436.
［48］	Sun Y, Chen L, Wang H, et al. Activation of aryl hydrocarbon receptor ameliorates rosacea⁃like eruptions in mice and suppresses the TLR signaling pathway in LL⁃37⁃induced HaCaT cells［J］. Toxicol Appl Pharmacol, 2022,451:116189. doi: 10. 1016/j.taap.2022.116189.

[1]	Zong Yangyongyi, Ma Chujun, Su Zhonglan. Eczematization following the treatment of psoriasis with biological agents: pathogenesis and management [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220578-e20220578.
[2]	Zhang Yue, Tao Meng, Li Min, Jiang Peiyu, Liu Yunyi, Liu Yixuan, Pan Ruoxin, Xu Yang. Severity assessment criteria for rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 182-185.
[3]	Pan Ruoxin, Gu Duoduo, Zhang Yue, Li Min, Tao Meng, Xu Yang. Metabolomics in rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 178-181.
[4]	Wei Ziyu, Yang Yong. Role of ion channels in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 174-177.
[5]	Li Ji, Xie Hongfu. How to avoid misdiagnosis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 119-122.
[6]	Jiang Xian, Song Deyu. Insights into rosacea from the perspective of psychosomatic medicine [J]. Chinese Journal of Dermatology, 2024, 57(2): 123-126.
[7]	Na Jun, Li Ruoyu, Zhong Shaomin, Yang Li, Wu Yan. Diagnosis and treatment of rosacea in the real world: a survey on the current status [J]. Chinese Journal of Dermatology, 2024, 57(2): 127-133.
[8]	Ma Guangrong, Xie Hongfu, Liu Jiashuang, Zhou Zhonglian, Zou Songqi, Huang Yingxue, Li Ji. Small intestinal bacterial overgrowth in patients with rosacea: prevalence and clinical features [J]. Chinese Journal of Dermatology, 2024, 57(2): 134-140.
[9]	Zhang Xiaodong, Wang Manya, Zhu Yingjie, Luo Tiande, Liu Xiaoming. Application of fluorescence staining in the detection of Demodex mites in the facial skin [J]. Chinese Journal of Dermatology, 2023, 56(8): 766-769.
[10]	Song Zhiqiang, Chen Qiquan, Ge Lan. Insights into the progress in targeted therapy of atopic dermatitis from the perspective of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(8): 718-723.
[11]	Tao Meng, Li Min, Liu Yixuan, Liu Yunyi, Jiang Peiyu, Zhang Jiawen, Nan Yuqing, Xu Yang. Correlation between rosacea and neuropsychiatric diseases [J]. Chinese Journal of Dermatology, 2023, 56(7): 693-697.
[12]	Mi Shuhong, Yu Yanqin, Hao Jinqi, Li Wei, Zhang Yang, Jia Ximei, Huang Yuxian, Sun Huaiyu, Shi Jihai. Analysis of imaging characteristics of papulopustular rosacea by high-frequency ultrasound combined with color Doppler flow imaging [J]. Chinese Journal of Dermatology, 2023, 56(6): 540-544.
[13]	Liang Yunsheng, Li Zhanhong, Wu Yibei. Progress in the treatment of chronic spontaneous urticaria: insights from the changes in the understanding of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(6): 552-558.
[14]	Li Rong, Zhang Jiaan, Chen Kun. Photoelectric therapy for rosacea [J]. Chinese Journal of Dermatology, 2023, 56(5): 468-470.
[15]	Li Jiaqi, Ye Feng, Ju Qiang. Symbiotic homeostasis of Staphylococcus epidermidis is associated with common skin disorders [J]. Chinese Journal of Dermatology, 2023, 56(5): 459-462.

Advances in the pathogenesis of rosacea

PDF

Knowledge

Abstract

Cite this article

share this article

References ［48］

Related Articles 15

Metrics

Comments

Recommended 10